Condition
Midface Contour Deficiencies
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Active Not Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06872359Not ApplicableActive Not Recruiting
Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling
NCT05262777Not ApplicableCompleted
Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
NCT03160716Not ApplicableCompleted
Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation
NCT05098457Not ApplicableWithdrawn
Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction
Showing all 4 trials